Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius Honored as “Overall Best Bioprocessing Supplier” Award...

11/03/2021 | 06:55am EST

Sartorius, a leading international partner of life science research and the biopharmaceutical industry, was named the award winner for "Overall Best Bioprocessing Supplier" at the Europe Bioprocessing Excellence Awards 2021. According to award organizer IMAPAC, the awards seek to recognize exceptional bioprocessing experts, organizations, and technologies that facilitate biomanufacturing excellence at enhanced speed, reduced cost, and superior quality across Europe and the rest of the world.

"Sartorius is proud of its leadership and innovations in bioprocessing and values the strong relationships we have built with partners and customers throughout the industry," said Christopher Mach, Head of Key Account Management at Sartorius." We remain committed to helping our customers create better patient outcomes through the development of new and improved therapies. We're honored to be named 'Overall Best Bioprocessing Supplier' at this year's Bioprocessing Excellence Awards."

The award ceremony was held in conjunction with Biologics Contract Manufacturing Europe 2021 and 4th Biologics World Nordic 2021 conference events, and René Fáber, Head of Bioprocess Solutions Division, Sartorius, accepted the award virtually on behalf of Sartorius. Winners were determined by a panel of four external judges who are industry professionals, community experts, regional representatives, and past winners.

Follow Sartorius on Twitter@Sartorius_Group and on LinkedIn.

Disclaimer

Sartorius AG published this content on 02 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2021 11:54:07 UTC.


ę Publicnow 2021
All news about SARTORIUS AG
01/04SARTORIUS VORZUEGE : Gets a Buy rating from JP Morgan
MD
2021SARTORIUS VORZUEGE : NorldLB gives a Neutral rating
MD
2021Sartorius Acquires Majority Stake in ALS Automated Lab Solutions
DJ
2021Sartorius To Buy 63% Interest In Germany's ALS Automated Lab Solutions
MT
2021Sartorius Aktiengesellschaft entered into an agreement to acquire a 62.5% stake in ALS ..
CI
2021SARTORIUS : and HOF Sonderanlagenbau Partnership Creates...
PU
2021Sartorius to Pay $11.3 Million COVID-19 Bonus to Employees
MT
2021SARTORIUS : employees to receive a bonus for their commitment and...
PU
2021Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
2021Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2021 3 397 M 3 853 M 3 853 M
Net income 2021 418 M 474 M 474 M
Net Debt 2021 1 885 M 2 139 M 2 139 M
P/E ratio 2021 67,2x
Yield 2021 0,33%
Capitalization 29 582 M 33 551 M 33 555 M
EV / Sales 2021 9,26x
EV / Sales 2022 8,07x
Nbr of Employees 12 952
Free-Float -
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 400,00 €
Average target price 488,55 €
Spread / Average Target 22,1%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-19.84%33 551
REVENIO GROUP OYJ-15.64%1 412
BIOTAGE AB (PUBL)-29.01%1 337
VAREX IMAGING CORPORATION-11.95%1 099
CELLAVISION AB (PUBL)3.57%875
RENALYTIX PLC-15.32%515